vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Industrial Logistics Properties Trust (ILPT). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $113.9M, roughly 1.6× Industrial Logistics Properties Trust). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -1.6%, a 2.5% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 3.1%). Industrial Logistics Properties Trust produced more free cash flow last quarter ($42.0M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 0.7%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Industrial Logistics Properties Trust is a real estate investment trust that owns and operates a portfolio of industrial and logistics real estate assets primarily across the United States. Its holdings include distribution centers, warehouses, and last-mile delivery properties, serving e-commerce, retail, manufacturing and supply chain operators to meet their storage and logistics operation needs.
FOLD vs ILPT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $113.9M |
| Net Profit | $1.7M | $-1.8M |
| Gross Margin | 85.7% | — |
| Operating Margin | 8.6% | -22.1% |
| Net Margin | 0.9% | -1.6% |
| Revenue YoY | 23.7% | 3.1% |
| Net Profit YoY | -88.5% | 92.6% |
| EPS (diluted) | $0.00 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $113.9M | ||
| Q3 25 | $169.1M | $110.9M | ||
| Q2 25 | $154.7M | $112.1M | ||
| Q1 25 | $125.2M | $111.9M | ||
| Q4 24 | $149.7M | $110.5M | ||
| Q3 24 | $141.5M | $108.9M | ||
| Q2 24 | $126.7M | $110.6M | ||
| Q1 24 | $110.4M | $112.2M |
| Q4 25 | $1.7M | $-1.8M | ||
| Q3 25 | $17.3M | $-21.6M | ||
| Q2 25 | $-24.4M | $-21.3M | ||
| Q1 25 | $-21.7M | $-21.5M | ||
| Q4 24 | $14.7M | $-24.1M | ||
| Q3 24 | $-6.7M | $-25.0M | ||
| Q2 24 | $-15.7M | $-23.2M | ||
| Q1 24 | $-48.4M | $-23.4M |
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — | ||
| Q1 24 | 87.7% | — |
| Q4 25 | 8.6% | -22.1% | ||
| Q3 25 | 20.3% | -29.4% | ||
| Q2 25 | -6.1% | -30.8% | ||
| Q1 25 | -6.3% | -26.9% | ||
| Q4 24 | 10.7% | -31.1% | ||
| Q3 24 | 15.3% | -33.5% | ||
| Q2 24 | 11.8% | -32.4% | ||
| Q1 24 | -25.1% | -31.7% |
| Q4 25 | 0.9% | -1.6% | ||
| Q3 25 | 10.2% | -19.4% | ||
| Q2 25 | -15.8% | -19.0% | ||
| Q1 25 | -17.3% | -19.2% | ||
| Q4 24 | 9.8% | -21.8% | ||
| Q3 24 | -4.8% | -22.9% | ||
| Q2 24 | -12.4% | -20.9% | ||
| Q1 24 | -43.9% | -20.9% |
| Q4 25 | $0.00 | $-0.02 | ||
| Q3 25 | $0.06 | $-0.33 | ||
| Q2 25 | $-0.08 | $-0.32 | ||
| Q1 25 | $-0.07 | $-0.33 | ||
| Q4 24 | $0.05 | $-0.37 | ||
| Q3 24 | $-0.02 | $-0.38 | ||
| Q2 24 | $-0.05 | $-0.35 | ||
| Q1 24 | $-0.16 | $-0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $94.8M |
| Total DebtLower is stronger | $392.7M | $4.2B |
| Stockholders' EquityBook value | $274.2M | $489.7M |
| Total Assets | $949.9M | $5.2B |
| Debt / EquityLower = less leverage | 1.43× | 8.56× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $94.8M | ||
| Q3 25 | $263.8M | $83.2M | ||
| Q2 25 | $231.0M | $58.6M | ||
| Q1 25 | $250.6M | $108.0M | ||
| Q4 24 | $249.9M | $131.7M | ||
| Q3 24 | $249.8M | $153.9M | ||
| Q2 24 | $260.1M | $146.2M | ||
| Q1 24 | $239.6M | $128.4M |
| Q4 25 | $392.7M | $4.2B | ||
| Q3 25 | $392.0M | $4.2B | ||
| Q2 25 | $391.3M | $4.2B | ||
| Q1 25 | $390.7M | $4.3B | ||
| Q4 24 | $390.1M | $4.3B | ||
| Q3 24 | $389.5M | $4.3B | ||
| Q2 24 | $388.9M | $4.3B | ||
| Q1 24 | $388.4M | $4.3B |
| Q4 25 | $274.2M | $489.7M | ||
| Q3 25 | $230.4M | $494.1M | ||
| Q2 25 | $204.3M | $519.1M | ||
| Q1 25 | $193.6M | $539.5M | ||
| Q4 24 | $194.0M | $562.0M | ||
| Q3 24 | $178.8M | $585.9M | ||
| Q2 24 | $132.5M | $618.3M | ||
| Q1 24 | $130.7M | $643.2M |
| Q4 25 | $949.9M | $5.2B | ||
| Q3 25 | $868.8M | $5.2B | ||
| Q2 25 | $815.3M | $5.2B | ||
| Q1 25 | $789.8M | $5.4B | ||
| Q4 24 | $785.0M | $5.4B | ||
| Q3 24 | $786.6M | $5.5B | ||
| Q2 24 | $749.5M | $5.5B | ||
| Q1 24 | $721.8M | $5.5B |
| Q4 25 | 1.43× | 8.56× | ||
| Q3 25 | 1.70× | 8.49× | ||
| Q2 25 | 1.92× | 8.09× | ||
| Q1 25 | 2.02× | 7.96× | ||
| Q4 24 | 2.01× | 7.65× | ||
| Q3 24 | 2.18× | 7.35× | ||
| Q2 24 | 2.93× | 6.96× | ||
| Q1 24 | 2.97× | 6.70× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $60.7M |
| Free Cash FlowOCF − Capex | $16.0M | $42.0M |
| FCF MarginFCF / Revenue | 8.6% | 36.9% |
| Capex IntensityCapex / Revenue | 0.2% | 16.4% |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $79.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $60.7M | ||
| Q3 25 | $35.7M | $22.7M | ||
| Q2 25 | $-26.5M | $18.4M | ||
| Q1 25 | $7.8M | $11.4M | ||
| Q4 24 | $-3.9M | $2.0M | ||
| Q3 24 | $-23.0M | $-3.4M | ||
| Q2 24 | $22.7M | $10.8M | ||
| Q1 24 | $-29.7M | $8.0M |
| Q4 25 | $16.0M | $42.0M | ||
| Q3 25 | $35.3M | $17.6M | ||
| Q2 25 | $-28.9M | $15.2M | ||
| Q1 25 | $7.5M | $5.0M | ||
| Q4 24 | $-4.2M | $-3.7M | ||
| Q3 24 | $-23.3M | $-5.9M | ||
| Q2 24 | $21.6M | $9.4M | ||
| Q1 24 | $-31.5M | $5.9M |
| Q4 25 | 8.6% | 36.9% | ||
| Q3 25 | 20.9% | 15.9% | ||
| Q2 25 | -18.7% | 13.5% | ||
| Q1 25 | 6.0% | 4.5% | ||
| Q4 24 | -2.8% | -3.4% | ||
| Q3 24 | -16.5% | -5.5% | ||
| Q2 24 | 17.0% | 8.5% | ||
| Q1 24 | -28.5% | 5.2% |
| Q4 25 | 0.2% | 16.4% | ||
| Q3 25 | 0.2% | 4.6% | ||
| Q2 25 | 1.6% | 2.9% | ||
| Q1 25 | 0.2% | 5.7% | ||
| Q4 24 | 0.2% | 5.2% | ||
| Q3 24 | 0.3% | 2.3% | ||
| Q2 24 | 0.9% | 1.3% | ||
| Q1 24 | 1.6% | 1.9% |
| Q4 25 | 9.62× | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.27× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
ILPT
Segment breakdown not available.
